Expo
view channel
view channel
view channel
view channel
view channel
view channel
view channel
view channel
view channel
Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathology
Industry
Events
Webinars
- Blood Metabolite Test Detects Early Cognitive Decline
- AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
- New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
- Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection
- Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
- Genetic Marker Predicts Early Heart Failure in Pulmonary Arterial Hypertension
- Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers
- cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample
- Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes
- ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery
- AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
- Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Fast and Easy Test Could Revolutionize Blood Transfusions
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
- Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
- FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
- Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
- Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
- Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
- Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
- Rapid Urine Test Speeds Antibiotic Selection for UTIs
- WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection
- Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
- Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
- Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
- Online Tool Supports Family Screening for Inherited Cancer Risk
- Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
- New Electronic Pipette Enhances Workflows with Touchscreen Control
- Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation
- Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development
- Integrated DNA Technologies Expands into Clinical Diagnostics
- Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
- Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
- Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
- Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
- International Consensus Standardizes Tumor Microbiota Detection and Reporting
- Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
- Researchers Identify Survival Pathway Undermining Targeted Cancer Drugs
- Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
- AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
- AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
- Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
- AI-Powered Tool to Transform Dermatopathology Workflow
Expo
- Blood Metabolite Test Detects Early Cognitive Decline
- AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample
- New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
- Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection
- Blood-Based Screening Test Targets Early Detection of Colorectal Cancer
- Genetic Marker Predicts Early Heart Failure in Pulmonary Arterial Hypertension
- Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers
- cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample
- Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes
- ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery
- AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
- Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Fast and Easy Test Could Revolutionize Blood Transfusions
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
- Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
- FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
- Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
- Microfluidic Chip Detects Cancer Recurrence from Immune Response Signals
- Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
- Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
- Rapid Urine Test Speeds Antibiotic Selection for UTIs
- WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection
- Breath Analysis Approach Offers Rapid Detection of Bacterial Infection
- Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
- Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
- Online Tool Supports Family Screening for Inherited Cancer Risk
- Portable Breath Sensor Detects Pneumonia Biomarkers in Minutes
- New Electronic Pipette Enhances Workflows with Touchscreen Control
- Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation
- Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development
- Integrated DNA Technologies Expands into Clinical Diagnostics
- Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
- Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
- Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
- Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
- International Consensus Standardizes Tumor Microbiota Detection and Reporting
- Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
- Researchers Identify Survival Pathway Undermining Targeted Cancer Drugs
- Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer
- AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
- AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
- Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma
- AI-Powered Tool to Transform Dermatopathology Workflow
.jpg)
_image.png "Image: Through neoadjuvant therapy combining chemotherapy with immune checkpoint inhibitors (ICI) for 46 LAGC patients and single-cell transcriptome sequencing, researchers found that tumor cells in the treatment-sensitive group specifically upregulated MHC-II (tumor-specific major histocompatibility complex class II, tsMHC-II) molecules (photo courtesy of Science China Press)")
Client Login